Venrock Healthcare Capital Partners III, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share (DNTH)

Filing Manager: Venrock Healthcare Capital Partners III, L.P.
Reporting Manager: Venrock Healthcare Capital Partners III, L.P.
Security: Dianthus Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: DNTH
Shares outstanding: 32,258,065 shares
Disclosed Ownership: 1,000,000 shares
Ownership: 3.1%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 17:58:13 UTC
Date of event: 30 Jun 2025
SEC: View on sec.gov

Reporting Managers (7)

Name	Ownership	Shares Owned	shared voting power	Signature	Title
Venrock Healthcare Capital Partners III, L.P.	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Co-Investment Holdings III, LLC	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Venrock Healthcare Capital Partners EG, L.P.	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
VHCP Management III, LLC	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By Sherman G. Souther, Authorized Signatory
VHCP Management EG, LLC	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By Sherman G. Souther, Authorized Signatory
Nimish Shah	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By Sherman G. Souther, Attorney-in-fact
Bong Y. Koh	3.1%	1,000,000	1,000,000	/s/ Sherman G. Souther	By Sherman G. Souther, Attorney-in-fact